微生物与感染
2025年1月9日 星期四   首页 |  主编心语 |  期刊介绍 |  编委阵容 |  投稿指南 |  出版道德 |  期刊订阅 |  联系我们 | English
微生物与感染  2021, Vol. 16 Issue (3): 145-163    DOI: 10.3969/j.issn.1673-6184.2021.03.001
  论著 本期目录 | 过刊浏览 | 高级检索 |
基于gp41近膜端外部区域中和表位天然构象的人类免疫缺陷病毒1型疫苗的设计
曹妙1,苏珊1,叶玲2,陆路1,杨庆来2,姜世勃1
1. 复旦大学上海医学院基础医学院教育部/卫健委/医科院医学分子病毒学重点实验室, 上海 200032; 2. 埃默里大学医学院微生物与免疫学系埃默里疫苗中心, 美国亚特兰大 GA30322
Human immunodeficiency virus-1 vaccine designed based on the natural conformation of the neutralizing epitope in gp41 membrane-proximal external region
CAO Miao1, SU Shan1, YE Ling2, LU Lu1, YANG Qinglai2, JIANG Shibo1
1. Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; 2. Department of Microbiology and Immunology and Emory Vaccine Center, School of Medicine, Emory University, Atlanta, GA 30322, USA
全文: PDF (3822 KB)   HTML (156)
输出: BibTeX | EndNote (RIS)      
摘要: 疫苗一直被视为终结人类免疫缺陷病毒1型和2 型(human immunodeficiency virus type 1/2,HIV-1/2)最有力的武器。位于HIV-1 gp41胞外域C末端的近膜端外部区域(membrane-proximal external region, MPER)是一个重要的抗原位点,但糖蛋白41(glycoprotein 41,gp41)在野生型HIV-1的包膜蛋白中并未充分暴露,单独的gp41或MPER多肽无法模拟gp120/gp41包膜蛋白在病毒包膜上的天然状态。本研究以HIV-1 gp41 MPER为抗原进行疫苗设计,以期能诱导产生具有强效中和作用的MPER特异性抗体。通过在gp41的N末端七肽重复域(N-terminal heptad repeat, CHR)和C末端七肽重复域(C-terminal heptad repeat, NHR)引入突变,阻断二者相互作用形成6螺旋(6-helix bundle, 6-HB)构象;使用不同来源的流感病毒HA1亚基替代gp120,以防止机体产生大量针对HA1的抗体,并构建一系列包含不同HA1亚基的HA/gp41-1605嵌合DNA。结果发现,在细胞上表达的嵌合疫苗抗原能更好地展示MPER上的中和表位,但不显示gp41上免疫优势抗原表位。使用构建的HA/gp41嵌合DNA疫苗对新西兰大耳兔进行肌肉内序贯免疫,提示该疫苗策略的确不可诱生高滴度的HA抗体或gp41的loop及6-HB特异性抗体,而能诱生MPER特异性抗体。然而,该抗体对HIV-1不具有中和作用,说明该疫苗策略还有待进一步优化。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
曹妙1
苏珊1
叶玲2
陆路1
杨庆来2
姜世勃1
关键词 人类免疫缺陷病毒1型疫苗糖蛋白41近膜端外部区域天然构象    
Abstract:Vaccine has long been regarded as the most powerful weapon to HIV, including HIV-1 and HIV-2. The membrane-proximal external region (MPER) located at the C-terminus of the extracellular domain of gp41 is a key antigenic site. However, gp41 is not well-exposed on the wild-type HIV-1 particle, and gp41 molecule or a MPER peptides alone cannot simulate the natural conformation of gp120/gp41 envelope protein on the viral membrane. In this study, we designed a series of chimeric HA/gp41-1605 DNA by introduced mutations in the gp41 NHR and CHR regions to block their interaction to form 6-HB and replacing HA1 using those from different influenza A viruses (IAVs) to prevent the production of a large amount of HA1-specific antibodies and to present the native conformation of the HIV-1 gp41 MPER. The results showed that chimeric vaccine antigens expressed on cells exhibited the neutralizing epitopes in MPER, but did not display the immunodominant antigen epitopes on gp41. After the sequential intramuscular immunization of New Zealand Rabbits with these HA/gp41-1605 chimeric DNA vaccines, we found that the chimeric vaccine could not elicit HA-, loop-, and 6-HB-specific antibodies. Although this vaccine can induce MPER-specific antibodies, but not HIV-1 neutralizing antibodies, suggesting that further optimization of this strategy is warranted.
Key wordsHuman immunodeficiency virus type 1 vaccine    Glycoprotein 41    Membrane-proximal external region    Natural conformation
ZTFEL:  R373.9  
基金资助:国家自然科学基金(81661128041)
通讯作者: 杨庆来,姜世勃   
引用本文:   
曹妙1,苏珊1,叶玲2,陆路1,杨庆来2,姜世勃1. 基于gp41近膜端外部区域中和表位天然构象的人类免疫缺陷病毒1型疫苗的设计[J]. 微生物与感染, 2021, 16(3): 145-163.
CAO Miao1, SU Shan1, YE Ling2, LU Lu1, YANG Qinglai2, JIANG Shibo1. Human immunodeficiency virus-1 vaccine designed based on the natural conformation of the neutralizing epitope in gp41 membrane-proximal external region. JOURNAL OF MICROBES AND INFECTIONS, 2021, 16(3): 145-163.
链接本文:  
http://jmi.fudan.edu.cn/CN/10.3969/j.issn.1673-6184.2021.03.001     或     http://jmi.fudan.edu.cn/CN/Y2021/V16/I3/145

版权所有 © 2008 《微生物与感染》编辑部
地址:上海市医学院路138号 邮编:200032
Tel:021-54237633 Fax:021-64434224    E-mail:jmi@fudan.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发  技术支持:support@magtech.com.cn